S100A8 and hepatocellular carcinoma: The methylation level of S100A8 in patients in the high-risk group was lower than that in patients in the low-risk group, indicating the important role of S100A8 in the progression of HCC, which also partly explains why HCC patients with hypomethylation of S100A8 had a shorter OS.